Cyanostatin B
Cyanostatin B, a cyanobacterial lipopeptide, is a leucine aminopeptidase M (LAP) inhibitor (IC50 = 12 ng/mL) . Cyanostatin B is a weak inhibitor of protein phosphatase (PP2A) and also exhibits weak inhibitory activity against angiotensin-converting enzyme (ACE), with an IC50 value of 130 μg/mL. Cyanostatin B demonstrates both cytotoxic and genotoxic effects on human hepatocytes, although non-toxic to Artemia salina. Cyanostatin B inhibits the proliferation of HepG2 cells, induces DNA single-strand breaks, and causes genomic instability.[1][2].
Product Specifications
CAS Number
850131-23-6
UNSPSC
12352209
Target
Aminopeptidase; Angiotensin-converting Enzyme (ACE) ; DNA/RNA Synthesis; Phosphatase
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
OC(C=C1)=CC=C1C[C@H](NC([C@@H](O)[C@H](N)CCCCCCC)=O)C(N(C)[C@@H]([C@@H](C)CC)C(N2[C@@H](CCC2)C(N[C@H](C(O)=O)CC3=CC=C(C=C3)O)=O)=O)=O
Molecular Formula
C40H59N5O9
Molecular Weight
753.92
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PDGFRA, CT (Platelet Derived Growth Factor Receptor, alpha, CD140A, PDGFR2, PDGFR-2, RHEPDGFRA)
PDGFRA, CT (Platelet Derived Growth Factor Receptor, alpha, CD140A, PDGFR2, PDGFR-2, RHEPDGFRA)
